Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan 16;27(1):4–14. doi: 10.1007/s40629-017-0046-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 4 — a Rate of emergency medication prescribed, rate of referrals to an allergist, rate of diagnostics performed and rate of venom immunotherapy (VIT) initiated in patients who received an early recommendation for follow-up during the acute treatment phase (n = 69) as compared to patients who did not receive this recommendation during acute treatment (n = 46), or did not remember/did not answer if a recommendation was received during acute treatment (n = 11). b–d Tree diagram of treatment paths reported by patients who received an early recommendation for follow-up (n = 69) (b), by patients who did not receive an early recommendation for follow-up (n = 46) (c) or did not remember/did not answer if a recommendation was received during acute treatment (n = 11) (d). Relevant endpoints: (1) early recommendation for follow-up received (b) not received (c), unknown (d)